Literature DB >> 2145276

Assembly of functional rhodopsin requires a disulfide bond between cysteine residues 110 and 187.

S S Karnik1, H G Khorana.   

Abstract

Cysteine residues 110 and 187 are essential for the formation of the correct bovine rhodopsin structure (Karnik, S. S., Sakmar, T. P., Chen, H.-B., and Khorana, H. G. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 8459-8463). We now show that the sulfhydryl groups of these 2 cysteine residues interact to form a disulfide bond. Rhodopsin mutants containing cysteine----serine substitutions were prepared as follows. In one mutant, CysVII, all the 10 cysteine residues of rhodopsin were replaced by serines. A second mutant, CysVIII, contained only C110 and C185; a third mutant, CysIX, contained only C185 and C187 while the fourth mutant, CysX, contained only C110 and C187. Only mutant CysX formed functional rhodopsin. Mutants CysVIII and CysIX reacted with [3H]iodoacetic acid showing the presence of free sulfhydryl groups while mutant CysX was inert to this reagent. CysX reacted with cyanide ion to form a thiocyanate derivative showing the presence of a disulfide bond. The C110-C187 disulfide bond is buried in rhodopsin because reactions with disulfide reducing agents and cyanide ion require prior treatment with denaturants.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145276

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

Review 2.  The significance of G protein-coupled receptor crystallography for drug discovery.

Authors:  John A Salon; David T Lodowski; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

3.  Molecular dynamics of rhodopsin and free opsin: computer simulation.

Authors:  Kh T Kholmurodov; T B Fel'dman; M A Ostrovskii
Journal:  Neurosci Behav Physiol       Date:  2007-02

4.  Structure and function in rhodopsin: Mass spectrometric identification of the abnormal intradiscal disulfide bond in misfolded retinitis pigmentosa mutants.

Authors:  J Hwa; J Klein-Seetharaman; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa.

Authors:  C H Sung; B G Schneider; N Agarwal; D S Papermaster; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor.

Authors:  H Y Lin; E H Kaji; G K Winkel; H E Ives; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

7.  The membrane proximal region of the cannabinoid receptor CB1 N-terminus can allosterically modulate ligand affinity.

Authors:  Jonathan F Fay; David L Farrens
Journal:  Biochemistry       Date:  2013-11-08       Impact factor: 3.162

8.  Analysis of protein structure in intact cells: crosslinking in vivo between introduced cysteines in the transmembrane domain of a bacterial chemoreceptor.

Authors:  A G Hughson; G F Lee; G L Hazelbauer
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

9.  Structure and function in rhodopsin: packing of the helices in the transmembrane domain and folding to a tertiary structure in the intradiscal domain are coupled.

Authors:  J Hwa; P Garriga; X Liu; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

10.  Retinal counterion switch in the photoactivation of the G protein-coupled receptor rhodopsin.

Authors:  Elsa C Y Yan; Manija A Kazmi; Ziad Ganim; Jian-Min Hou; Douhai Pan; Belinda S W Chang; Thomas P Sakmar; Richard A Mathies
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.